ACHC's stock is gaining due to broader market strength, with the Nasdaq index up 1.23%. This positive sentiment could create further buying opportunities for investors focused on healthcare stocks amidst overall market movements.
ACHC shares dropped 22.7% to $12.74 in pre-market trading. The drop follows an update on full-year 2025 guidance. Increased patient-related litigation costs prompted revised liability reserve updates.
Engine Capital calls for drastic changes in Acadia's board. ACHC shares have fallen 71% over the past year. Hedge fund urges halt on new projects and better capital allocation. Acadia's stock is currently deemed deeply undervalued. Company faces federal investigations impacting its operations.